CD8A and neoplasm: High frequency of epitopes of HBV X displayed at HBV core protein elicited epitope-specific CD8+ T cells and a more forceful response than a single peptide showing that multiepitope-loaded VLP augment immunogenicity for each epitope by increasing the number of CTLs resulting in a significant anti-tumor response [28].